Advertisement

Topics

Latest "MetaLogics Corporation" News Stories

00:15 EST 23rd February 2019 | BioPortfolio

Here are the most relevant search results for "MetaLogics Corporation" found in our extensive news archives from over 250 global news sources.

More Information about MetaLogics Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about MetaLogics Corporation for you to read. Along with our medical data and news we also list MetaLogics Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of MetaLogics Corporation Companies for you to search.

Showing "MetaLogics Corporation" News Articles 1–25 of 536

Relevant

Bavarian Nordic A/S - Articles of Association

Updated Articles of Association for Bavarian Nordic A/S BavarianNordicArticlesofAssociationThis announcement is distributed by West Corporation on behalf of West Corporation clients.The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.Source: Bavarian Nordic A/S via Globenewswire


Ambu A/S: Articles of Association February 2019

Complete Articles of Association February 2019 Complete AoA February 2019This announcement is distributed by West Corporation on behalf of West Corporation clients.The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.Source: Ambu A/S via Globenewswire

Ambu A/S: Articles of Association November 2018

  Attached the updated Articles of Association November 2018 Complete Articles of Association November 2018This announcement is distributed by West Corporation on behalf of West Corporation clients.The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.Source: Ambu A/S via Globenewswire


Ambu A/S: Allan Søgaard Larsen withdraws from Ambu's Board of Directors

Allan Søgaard Larsen, who since 2011 has been a member of the Board in Ambu A/S, has for personal reasons decided to withdraw from the Board with immediate effect. Company_Announcement_no. 6 2018_19This announcement is distributed by West Corporation on behalf of West Corporation clients.The issuer of this announcement warrants that they are solely responsible for the content, accurac...

Ambu A/S: Articles of Association December 2018

  Attached Complete Articles of Association December 2018 Complete Articles of Association December 2018This announcement is distributed by West Corporation on behalf of West Corporation clients.The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.Source: Ambu A/S via Globenewswire

Mandatory notification of trade

Valborg Godal Vold, COO of Vistin Pharma ASA, and a primary insider, has on 18 September 2018 sold 50,000 shares in Vistin Pharma ASA at an average price of NOK 10.58 per share. Following this sale Valborg Godal Vold holds 50,000 shares in Vistin Pharma ASA. This announcement is distributed by West Corporation on behalf of West Corporation clients.The issuer of this announcement warrants that...

Arrayit Corporation and TeleChem International Inc Celebrate 25 Years in Business

Sunnyvale, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that management and staff are commemorating its 25-year business anniversary. On November 1, 1993, with two telephones and seed capital borrowed from their parents, entrepreneurs Rene Schena and Todd Martinsky founded industrial and specialty chemicals manu...

Arrayit Corporation Announces Chief Executive Officer Letter to Shareholders

Sunnyvale, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces a letter to shareholders from Arrayit Chief Executive Officer Rene Schena.  The letter is downloadable at this link: 

Arrayit Corporation Announces Allergy Testing Agreement with Sutter Health

Sunnyvale, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces an allergy testing agreement with Northern California healthcare leader Sutter Health. The company is providing its proprietary microarray-based finger stick allergy testing services to Sutter Health via doctors in the Sutter Health-affiliated Palo Alto Med...

Marrone Bio Innovations Announces Distribution Partnership with Hop Tri Investment Corporation in Vietnam

Regalia®, Grandevo® and Majestene® to Offer Vietnamese Growers Effective Biological Solutions as Regional Chemical Pesticide Reduction Begins DAVIS, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, to...

Novan Extends Technical Production Capacity and Reaches Agreement with Orion Corporation

External manufacturing agreement reached to enable production of clinical trial materials for SB204 and the acne indication, with the potential to include additional product candidatesExtension of capacity complements existing internal operations, proprietary technological knowledge, intellectual property strategy and production skillsAgreement aligns with and supports global business development...

Arrayit Corporation Nationwide Allergy Testing Network Doubles to More than 400 Healthcare Clinics

Sunnyvale, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports that its nationwide allergy testing consortium has more than doubled in the past six months to 410 medical clinics. The rapidly expanding network using the company’s powerful finger stick allergy testing services comprises 33 of the 48 continuous United St...

Arrayit Corporation Receives Approval for In-Store Promotions by a Major Retail Chain

Sunnyvale, Aug. 13, 2018 (GLOBE NEWSWIRE) -- August 13, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, has been approved for in-store allergy testing promotions by a major United States retailer.  Arrayit sales and marketing experts will conduct allergy test promotions in-store, and medical professionals at in-store clinics will col...

Probably Relevant

Arrayit Corporation Announces Brands Expansion of Proprietary Finger Stick Allergy Testing

Sunnyvale, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces expansion of its proprietary finger stick microarray allergy testing platform to a growing number of major market brands. Highly automated Arrayit technology is inherently suited to leveraging multiple brands and their unique venues and relationships to rea...

International Stem Cell Corporation Granted Key US Patent Protecting Anti-Aging Business

CARLSBAD, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based, clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that the United States Patent and Trademark Office (USPTO) has granted the Company US Patent No...

Arrayit Corporation Aces Three Consecutive Rounds of Proficiency Testing with the College of American Pathologists

Sunnyvale, Oct. 08, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports that its clinical team aced three consecutive rounds of blinded-specimen Proficiency Testing (PT) with the College of American Pathologists (CAP).  The SC-2017, SA-2018 and SB-2018 triannual CAP Diagnostic Immunology Surveys require highly quantitative measu...

International Stem Cell Corporation Raised Funds Through a Private Placement at Premium to Market

CARLSBAD, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that it raised $500,000 from a private investor not affiliated with the Company or its managemen...

Geron Corporation Reports Third Quarter 2018 Financial Results and Recent Company Events

Imetelstat program transition proceeding, including plans to initiate Phase 3 portion of IMerge Abstracts for IMbark and IMerge accepted for oral presentation at American Society of Hematology Meeting (ASH) in December Conference call scheduled for 4:30 p.m. ET today MENLO PARK, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced recent company events a...

Arrayit Corporation Allergy Testing Services Endorsed by Leading Pediatrics Medical Group

Sunnyvale, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports that its proprietary microarray-based finger stick allergy testing services are endorsed by prestigious health and wellness leader First Pediatrics Medical Group. Headquartered in Fresno, California USA, First Pediatrics Medical Group provides premium healthc...

International Stem Cell Corporation Publishes Successful Results in Traumatic Brain Injury

CARLSBAD, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that the results of the Company’s preclinical studies in traumatic brain injury (TBI) have been...

Terra Tech Corporation to Present at the 11th Annual LD Micro Main Event on December 5th

IRVINE, Calif., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC) (“Terra Tech”) or (the “Company”), a vertically integrated cannabis-focused agriculture company, today announced that its Chief Executive Officer, Derek Peterson, will present at the LD Micro Conference on December 5, 2018 at 1:30PM PST / 4:30PM EST at the Luxe Sunset Bel Air Hotel in Los Angeles, Californi...

International Stem Cell Corporation Granted Key US Patent Protecting Lead Therapeutic Program

CARLSBAD, Calif., Aug. 21, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that the United States Patent and Trademark Office (USPTO) has granted the Company a key patent ...

Global and Asia Instant Adhesive Market Status and Future Forecast 20132023 [Report Updated: 20082018] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:Asia Market by company, Type, Application RegionPart 410:Key Regions of Asia Market by Type, ApplicationPart 11:Company information, Sales, Cost, Margin etc.Part 12:ConclusionMarket Segment as fo...

Arrayit Corporation Launches Patient Data Solutions Allergy Testing Portal for Doctors and Clinics

Sunnyvale, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, launches a fully automated allergy testing portal for doctors and clinics to streamline and accelerate the allergy testing and treatment process. The Patient Data Solutions (PDS) allergy-testing suite is secure and fully compliant with Health Insurance Portability an...

International Stem Cell Corporation Doses Tenth Patient in Parkinson's Disease Clinical Trial

CARLSBAD, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today that the second patient of the third cohort of the clinical trial for Parkinson's disease was successfu...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks